Bavarian Nordic A/S (OTCMKTS:BVNRY) Stock Passes Below 200-Day Moving Average – What’s Next?

Bavarian Nordic A/S (OTCMKTS:BVNRY) shares passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $8.46 and traded as low as $8.20. Bavarian Nordic A/S shares last traded at $8.24, with a volume of 1,996 shares traded.

Bavarian Nordic A/S Stock Up 1.5%

The firm has a market cap of $1.95 billion, a price-to-earnings ratio of 11.94 and a beta of 1.44. The company’s 50-day moving average price is $7.66 and its 200-day moving average price is $8.46.

Bavarian Nordic A/S (OTCMKTS:BVNRY) last issued its quarterly earnings results on Friday, May 9th. The company reported $0.13 earnings per share (EPS) for the quarter. The business had revenue of $189.89 million for the quarter. Bavarian Nordic A/S had a net margin of 18.33% and a return on equity of 10.65%. On average, sell-side analysts predict that Bavarian Nordic A/S will post 0.67 earnings per share for the current fiscal year.

About Bavarian Nordic A/S

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.